The challenges of gout flare reporting: mapping flares during a randomized controlled trial

[1]  J. Singh,et al.  Brief Report: Validation of a Definition of Flare in Patients With Established Gout , 2018, Arthritis & rheumatology.

[2]  R. Terkeltaub,et al.  Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial , 2017, Arthritis & rheumatology.

[3]  K. Saag,et al.  Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study) , 2017, Arthritis & rheumatology.

[4]  A. So,et al.  Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study) , 2016, Annals of the rheumatic diseases.

[5]  T. Merriman,et al.  Gout , 2016, The Lancet.

[6]  Robert L. Martin,et al.  A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout , 2016, Arthritis & rheumatology.

[7]  W. Taylor,et al.  What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions , 2016, The Patient - Patient-Centered Outcomes Research.

[8]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.

[9]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.

[10]  F. Perez-Ruiz,et al.  Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout , 2015, Arthritis care & research.

[11]  C. Bode,et al.  Experiences of gout-related disability from the patients’ perspective: a mixed methods study , 2014, Clinical Rheumatology.

[12]  J. Singh,et al.  Developing a provisional definition of flare in patients with established gout. , 2012, Arthritis and rheumatism.

[13]  K. Rome,et al.  Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study , 2012, Arthritis care & research.

[14]  J. Singh,et al.  Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10 , 2011, The Journal of Rheumatology.

[15]  A. So,et al.  Extended Report , 2022 .

[16]  N. Dalbeth,et al.  The Experience and Impact of Living With Gout: A Study of Men With Chronic Gout Using a Qualitative Grounded Theory Approach , 2011, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[17]  I. Reid,et al.  Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial , 2010, Annals of the rheumatic diseases.

[18]  R. Terkeltaub,et al.  Gout disease-specific quality of life and the association with gout characteristics , 2010, Patient related outcome measures.

[19]  J. Singh,et al.  Progress in Measurement Instruments for Acute and Chronic Gout Studies , 2009, The Journal of Rheumatology.

[20]  J. Singh,et al.  Outcome Domains for Studies of Acute and Chronic Gout , 2009, The Journal of Rheumatology.

[21]  R. Shewchuk,et al.  Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping. , 2009, Arthritis and rheumatism.

[22]  H. Schumacher,et al.  Febuxostat compared with allopurinol in patients with hyperuricemia and gout. , 2005, The New England journal of medicine.

[23]  M. Abel,et al.  Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. , 2004, The Journal of rheumatology.

[24]  W. Downie,et al.  Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. , 1987, British journal of clinical pharmacology.

[25]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..